Cutting Costs with a CDMO: Strategies for Success in Biopharmaceutical Manufacturing

Biopharmaceutical companies are utilising Contract Development and Manufacturing Organizations (CDMOs) to scale up production, mitigate risks and cut costs. CDMOs provide advanced facilities, technologies and regulatory expertise, allowing companies to focus on their core operations. Strategies include reducing the cost of goods sold, managing inventory effectively, and implementing robust supply chain strategies to minimize disruptions. The emerging need for complex biologics further amplifies the significance of CDMOs in the industry.